Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001490829-25-000007

Director acquired 302 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2025-11-03 Other acquisition 10b5-1 +13 $2.80 $36 44,504 D
Jones James Director 2025-11-04 Other acquisition 10b5-1 +13 $2.82 $37 44,517 D
Jones James Director 2025-11-05 Other acquisition 10b5-1 +13 $2.53 $33 44,530 D
Jones James Director 2025-11-06 Other acquisition 10b5-1 +13 $2.27 $30 44,543 D
Jones James Director 2025-11-07 Other acquisition 10b5-1 +13 $2.19 $28 44,556 D
Jones James Director 2025-11-10 Other acquisition 10b5-1 +16 $2.11 $34 44,572 D
Jones James Director 2025-11-11 Other acquisition 10b5-1 +16 $2.06 $33 44,588 D
Jones James Director 2025-11-12 Other acquisition 10b5-1 +16 $1.99 $32 44,604 D
Jones James Director 2025-11-13 Other acquisition 10b5-1 +16 $2.17 $35 44,620 D
Jones James Director 2025-11-14 Other acquisition 10b5-1 +16 $2.15 $34 44,636 D
Jones James Director 2025-11-17 Other acquisition 10b5-1 +17 $2.17 $37 44,653 D
Jones James Director 2025-11-18 Other acquisition 10b5-1 +17 $1.98 $34 44,670 D
Jones James Director 2025-11-19 Other acquisition 10b5-1 +17 $2.01 $34 44,687 D
Jones James Director 2025-11-20 Other acquisition 10b5-1 +17 $1.99 $34 44,704 D
Jones James Director 2025-11-21 Other acquisition 10b5-1 +17 $1.96 $33 44,721 D
Jones James Director 2025-11-24 Other acquisition 10b5-1 +18 $2.10 $38 44,739 D
Jones James Director 2025-11-25 Other acquisition 10b5-1 +18 $2.21 $40 44,757 D
Jones James Director 2025-11-26 Other acquisition 10b5-1 +18 $2.17 $39 44,775 D
Jones James Director 2025-11-28 Other acquisition 10b5-1 +18 $2.41 $43 44,793 D
Loading xslF345X05/wk-form4_1764626786.xml…